We’re thrilled to share that Autolomous CEO & Co-founder, Alexander Seyf, is featured in Discover Pharma’s latest article on “Unlocking collective intelligence: Why cell and gene therapy needs a data-sharing revolution”, which explores how collaboration, not competition, is vital for overcoming bottlenecks across the CGT industry.

The interview highlights:
⭐ The quantifiable impact of siloed data and concrete examples of how shared data could have prevented setbacks in CGT development
⭐ How Autolomous addresses common barriers to collaboration, such as competitive concerns and intellectual property, through secure data governance and robust legal frameworks
⭐ Our commitment to fostering a more collaborative CGT ecosystem, through initiatives such as Act for Hope, which is actively building trusted partnerships across the industry to drive large-scale change and make therapies more accessible

This feature underscores Autolomous’ dedication to accelerating the delivery of therapies to patients by promoting a more open and efficient industry.

Read the full article here.